250
Participants
Start Date
June 22, 2020
Primary Completion Date
October 15, 2025
Study Completion Date
December 27, 2026
CC-94676
Specified dose on specified days
CC1083611
Specified dose on specified days
CC1083610
Specified dose on specified days
Local Institution - 112, New York
Local Institution - 109, New York
Local Institution - 105, New York
Local Institution - 120, Allentown
Local Institution - 113, Philadelphia
Local Institution - 122, Washington D.C.
Local Institution - 108, Baltimore
Local Institution - 106, Durham
Local Institution - 121, Thomasville
Local Institution - 103, Sarasota
Local Institution - 117, Ann Arbor
Local Institution - 102, Grand Rapids
Local Institution - 111, Madison
Local Institution - 107, Dallas
Local Institution - 119, Houston
Local Institution - 101, San Antonio
Local Institution - 115, Seattle
Local Institution - 116, Stanford
Local Institution - 104, Boston
Lead Sponsor
Celgene
INDUSTRY